LeonaBio Q4 EPS $(2.77) Misses $(0.84) Estimate

LeonaBio (NASDAQ: LONA) reported a Q4 loss of $(2.77) per share, significantly missing the analyst consensus estimate of $(0.84) by 229.76%. This represents a 28.97% increase in losses compared to $(3.90) per share from the same period last year.